Sfoglia per Autore
Characterization of NAD uptake in mammalian cells
2008-01-01 Billington, R. A.; Travelli, C.; Ercolano, E.; Galli, U.; Roman, C. B.; Grolla, A. A.; Canonico, P. L.; Condorelli, F.; Genazzani, A. A.
NAD depletion by FK866 induces autophagy
2008-01-01 Billington, R. A.; Genazzani, A. A.; Travelli, C.; Condorelli, F.
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry
2010-01-01 Colombano, G.; Travelli, C.; Galli, U.; Caldarelli, A.; Chini, M. G.; Canonico, P. L.; Sorba, G.; Bifulco, G.; Tron, G. C.; Genazzani, A. A.
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells
2011-01-01 Travelli, C.; Drago, V.; Maldi, E.; Kaludercic, N.; Galli, U.; Boldorini, R.; Di Lisa, F.; Tron, G. C.; Canonico, P. L.; Genazzani, A. A.
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury
2012-01-01 Esposito, E.; Impellizzeri, D.; Mazzon, E.; Fakhfouri, G.; Rahimian, R.; Travelli, C.; Tron, G. C.; Genazzani, A. A.; Cuzzocrea, S.
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors
2013-01-01 Galli, U.; Travelli, C.; Massarotti, A.; Fakhfouri, G.; Rahimian, R.; Tron, G. C.; Genazzani, A. A.
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions
2013-01-01 Maldi, E.; Travelli, C.; Caldarelli, A.; Agazzone, N.; Cintura, S.; Galli, U.; Scatolini, M.; Ostano, P.; Miglino, B.; Chiorino, G.; Boldorini, R.; Genazzani, A. A.
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents
2015-01-01 Galli, U.; Travelli, C.; Aprile, S.; Arrigoni, E.; Torretta, S.; Grosa, G.; Massarotti, A.; Sorba, G.; Canonico, P. L.; Genazzani, A. A.; Tron, G. C.
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
2015-01-01 Grolla, A. A.; Torretta, S.; Gnemmi, I.; Amoruso, A.; Orsomando, G.; Gatti, M.; Caldarelli, A.; Lim, D.; Penengo, L.; Brunelleschi, S.; Genazzani, A. A.; Travelli, C.
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement
2015-01-01 Theeramunkong, S.; Galli, U.; Grolla, A. A.; Caldarelli, A.; Travelli, C.; Massarotti, A.; Troiani, M. P.; Alisi, M. A.; Orsomando, G.; Genazzani, A. A.; Tron, G. C.
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine
2016-01-01 Grolla, A. A.; Travelli, C.; Genazzani, A. A.; Sethi, J. K.
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities?
2016-01-01 Caprioglio, D.; Torretta, S.; Ferrari, M.; Travelli, C.; Grolla, A. A.; Condorelli, F.; Genazzani, A. A.; Minassi, A.
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis
2016-01-01 Rosti, V.; Campanelli, R.; Massa, M.; Viarengo, G.; Villani, L.; Poletto, V.; Bonetti, E.; Catarsi, P.; Magrini, U.; Grolla, A. A.; Travelli, C.; Genazzani, A. A.; Barosi, G.
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases
2017-01-01 Amici, A.; Grolla, A. A.; Del Grosso, E.; Bellini, R.; Bianchi, M.; Travelli, C.; Garavaglia, S.; Sorci, L.; Raffaelli, N.; Ruggieri, S.; Genazzani, A. A.; Orsomando, G.
Metabolic regulation of suppressive myeloid cells in cancer
2017-01-01 Sica, A.; Strauss, L.; Consonni, F. M.; Travelli, C.; Genazzani, A.; Porta, C.
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity
2017-01-01 Travelli, C.; Aprile, S.; Rahimian, R.; Grolla, A. A.; Rogati, F.; Bertolotti, M.; Malagnino, F.; Di Paola, R.; Impellizzeri, D.; Fusco, R.; Mercalli, V.; Massarotti, A.; Stortini, G.; Terrazzino, S.; Del Grosso, E.; Fakhfouri, G.; Troiani, M. P.; Alisi, M. A.; Grosa, G.; Sorba, G.; Canonico, P. L.; Orsomando, G.; Cuzzocrea, S.; Genazzani, A. A.; Galli, U.; Tron, G. C.
NAMPT: A pleiotropic modulator of monocytes and macrophages
2018-01-01 Travelli, C.; Colombo, G.; Mola, S.; Genazzani, A. A.; Porta, C.
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders
2018-01-01 Serafini, M.; Griglio, A.; Aprile, S.; Seiti, F.; Travelli, C.; Pattarino, F.; Grosa, G.; Sorba, G.; Genazzani, A. A.; Gonzalez-Rodriguez, S.; Butron, L.; Devesa, I.; Fernandez-Carvajal, A.; Pirali, T.; Ferrer-Montiel, A.
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group
2019-01-01 Travelli, C.; Aprile, S.; Mattoteia, D.; Colombo, G.; Clemente, N.; Scanziani, E.; Terrazzino, S.; Alisi, M. A.; Polenzani, L.; Grosa, G.; Genazzani, A. A.; Tron, G. C.; Galli, U.
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells
2019-01-01 Travelli, C.; Consonni, F. M.; Sangaletti, S.; Storto, M.; Morlacchi, S.; Grolla, A. A.; Galli, U.; Tron, G. C.; Portararo, P.; Rimassa, L.; Pressiani, T.; Mazzone, M.; Trovato, R.; Ugel, S.; Bronte, V.; Tripodo, C.; Colombo, M. P.; Genazzani, A. A.; Sica, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Characterization of NAD uptake in mammalian cells | 1-gen-2008 | Billington, R. A.; Travelli, C.; Ercolano, E.; Galli, U.; Roman, C. B.; Grolla, A. A.; Canonico, P. L.; Condorelli, F.; Genazzani, A. A. | |
NAD depletion by FK866 induces autophagy | 1-gen-2008 | Billington, R. A.; Genazzani, A. A.; Travelli, C.; Condorelli, F. | |
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry | 1-gen-2010 | Colombano, G.; Travelli, C.; Galli, U.; Caldarelli, A.; Chini, M. G.; Canonico, P. L.; Sorba, G.; Bifulco, G.; Tron, G. C.; Genazzani, A. A. | |
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells | 1-gen-2011 | Travelli, C.; Drago, V.; Maldi, E.; Kaludercic, N.; Galli, U.; Boldorini, R.; Di Lisa, F.; Tron, G. C.; Canonico, P. L.; Genazzani, A. A. | |
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury | 1-gen-2012 | Esposito, E.; Impellizzeri, D.; Mazzon, E.; Fakhfouri, G.; Rahimian, R.; Travelli, C.; Tron, G. C.; Genazzani, A. A.; Cuzzocrea, S. | |
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors | 1-gen-2013 | Galli, U.; Travelli, C.; Massarotti, A.; Fakhfouri, G.; Rahimian, R.; Tron, G. C.; Genazzani, A. A. | |
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions | 1-gen-2013 | Maldi, E.; Travelli, C.; Caldarelli, A.; Agazzone, N.; Cintura, S.; Galli, U.; Scatolini, M.; Ostano, P.; Miglino, B.; Chiorino, G.; Boldorini, R.; Genazzani, A. A. | |
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents | 1-gen-2015 | Galli, U.; Travelli, C.; Aprile, S.; Arrigoni, E.; Torretta, S.; Grosa, G.; Massarotti, A.; Sorba, G.; Canonico, P. L.; Genazzani, A. A.; Tron, G. C. | |
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma | 1-gen-2015 | Grolla, A. A.; Torretta, S.; Gnemmi, I.; Amoruso, A.; Orsomando, G.; Gatti, M.; Caldarelli, A.; Lim, D.; Penengo, L.; Brunelleschi, S.; Genazzani, A. A.; Travelli, C. | |
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement | 1-gen-2015 | Theeramunkong, S.; Galli, U.; Grolla, A. A.; Caldarelli, A.; Travelli, C.; Massarotti, A.; Troiani, M. P.; Alisi, M. A.; Orsomando, G.; Genazzani, A. A.; Tron, G. C. | |
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine | 1-gen-2016 | Grolla, A. A.; Travelli, C.; Genazzani, A. A.; Sethi, J. K. | |
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? | 1-gen-2016 | Caprioglio, D.; Torretta, S.; Ferrari, M.; Travelli, C.; Grolla, A. A.; Condorelli, F.; Genazzani, A. A.; Minassi, A. | |
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis | 1-gen-2016 | Rosti, V.; Campanelli, R.; Massa, M.; Viarengo, G.; Villani, L.; Poletto, V.; Bonetti, E.; Catarsi, P.; Magrini, U.; Grolla, A. A.; Travelli, C.; Genazzani, A. A.; Barosi, G. | |
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases | 1-gen-2017 | Amici, A.; Grolla, A. A.; Del Grosso, E.; Bellini, R.; Bianchi, M.; Travelli, C.; Garavaglia, S.; Sorci, L.; Raffaelli, N.; Ruggieri, S.; Genazzani, A. A.; Orsomando, G. | |
Metabolic regulation of suppressive myeloid cells in cancer | 1-gen-2017 | Sica, A.; Strauss, L.; Consonni, F. M.; Travelli, C.; Genazzani, A.; Porta, C. | |
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity | 1-gen-2017 | Travelli, C.; Aprile, S.; Rahimian, R.; Grolla, A. A.; Rogati, F.; Bertolotti, M.; Malagnino, F.; Di Paola, R.; Impellizzeri, D.; Fusco, R.; Mercalli, V.; Massarotti, A.; Stortini, G.; Terrazzino, S.; Del Grosso, E.; Fakhfouri, G.; Troiani, M. P.; Alisi, M. A.; Grosa, G.; Sorba, G.; Canonico, P. L.; Orsomando, G.; Cuzzocrea, S.; Genazzani, A. A.; Galli, U.; Tron, G. C. | |
NAMPT: A pleiotropic modulator of monocytes and macrophages | 1-gen-2018 | Travelli, C.; Colombo, G.; Mola, S.; Genazzani, A. A.; Porta, C. | |
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders | 1-gen-2018 | Serafini, M.; Griglio, A.; Aprile, S.; Seiti, F.; Travelli, C.; Pattarino, F.; Grosa, G.; Sorba, G.; Genazzani, A. A.; Gonzalez-Rodriguez, S.; Butron, L.; Devesa, I.; Fernandez-Carvajal, A.; Pirali, T.; Ferrer-Montiel, A. | |
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group | 1-gen-2019 | Travelli, C.; Aprile, S.; Mattoteia, D.; Colombo, G.; Clemente, N.; Scanziani, E.; Terrazzino, S.; Alisi, M. A.; Polenzani, L.; Grosa, G.; Genazzani, A. A.; Tron, G. C.; Galli, U. | |
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells | 1-gen-2019 | Travelli, C.; Consonni, F. M.; Sangaletti, S.; Storto, M.; Morlacchi, S.; Grolla, A. A.; Galli, U.; Tron, G. C.; Portararo, P.; Rimassa, L.; Pressiani, T.; Mazzone, M.; Trovato, R.; Ugel, S.; Bronte, V.; Tripodo, C.; Colombo, M. P.; Genazzani, A. A.; Sica, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile